# Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

> **NCT00003113** · PHASE2 · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **DRUG:** lomustine
- **DRUG:** procarbazine hydrochloride
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003113
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-07
- **Primary completion:** 2002-12
- **Final completion:** 2002-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003113, "Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*